Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug - Bloomberg.com
  Eli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1s - WIRED
  Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials - Yahoo Finance
  Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand - Reuters
  This AI Trader Bought Meta Stock and Dumped Eli Lilly - Barron's
  Weight loss drugs are blowing up the U.S. trade deficit. Trump is blaming Ireland - Quartz
  Key deals this week: Couchbase, Eli Lilly, NTT Data, QXO, US Steel and more - Seeking Alpha
  Notable healthcare headlines for the week: Eli Lilly, Novavax and Sarepta Therapeutics in focus - MSN